Spire (NYSE:SR) Reaches New 12-Month High - Still a Buy?

Spire's share price hit a new 52-week high, but analysts have mixed views on the stock's future performance.

Published on Feb. 27, 2026

Got story updates? Submit your updates here. ›

Spire Inc. (NYSE:SR), a natural gas distribution company headquartered in St. Louis, Missouri, saw its share price reach a new 52-week high of $92.55 on Friday. The stock closed at $92.84, with a trading volume of 58,954 shares. Analysts have provided mixed sentiment on the company, with Zacks raising full-year EPS estimates for fiscal years 2026-2028 but trimming several near-term quarterly EPS forecasts.

Why it matters

Spire's new 52-week high price point suggests investors are bullish on the company's long-term prospects, but the mixed analyst sentiment indicates there may be some short-term uncertainty around the company's performance. As a regulated natural gas distributor, Spire's financial performance is closely tied to factors like weather, customer demand, and regulatory environment, making it important for investors to closely monitor the company's outlook.

The details

Zacks raised Spire's full-year EPS estimates for fiscal years 2026-2028, signaling an improved medium-term earnings outlook. However, the research firm also trimmed several near-term quarterly EPS forecasts, indicating weaker expected sequential performance in specific quarters. Additionally, a filing from Dimensional Fund Advisors related to a separate U.K. company, Spire Healthcare Group PLC, caused some investor confusion due to the similar ticker symbol.

  • Spire's share price reached a new 52-week high on Friday, February 27, 2026.
  • Zacks raised Spire's full-year EPS estimates for fiscal years 2026-2028.

The players

Spire Inc.

A regulated natural gas distribution company headquartered in St. Louis, Missouri, serving more than 1.7 million residential, commercial, and industrial customers across the central and southern United States.

Zacks

A research firm that provides investment research and analysis, including raising and trimming earnings estimates for Spire.

Dimensional Fund Advisors

An investment management firm that filed a Form 8.3 disclosure related to a separate U.K. company, Spire Healthcare Group PLC, which caused some investor confusion due to the similar ticker symbol.

Got photos? Submit your photos here. ›

What they’re saying

“Zacks raised FY2026, FY2027 and FY2028 full‑year EPS views (FY2026 to $5.29, FY2027 to $5.66, FY2028 to $6.05), which signals an improved medium‑term earnings outlook relative to prior estimates and can support valuation.”

— Zacks, Research Firm (MarketBeat)

“Zacks lifted several quarterly estimates that matter for near‑term cadence (notably Q2 2026 to $3.78 and Q2 2027 to $3.92, and Q1 2027 to $1.76), suggesting stronger expected seasonal performance in those periods.”

— Zacks, Research Firm (MarketBeat)

“Zacks trimmed several near‑term quarterly EPS forecasts (Q3 2026 to $0.15 from $0.20; Q3 2027 to $0.17 from $0.26; Q1 2028 to $1.73 from $1.82; Q4 2026 and Q4 2027 both revised lower), indicating weaker expected sequential performance in specific quarters and adding short‑term uncertainty.”

— Zacks, Research Firm (MarketBeat)

What’s next

The judge in the case will decide on Tuesday whether or not to allow Walker Reed Quinn out on bail.

The takeaway

Spire's new 52-week high price point suggests long-term investor optimism, but the mixed analyst sentiment indicates potential short-term performance challenges. As a regulated utility, Spire's financial results are tied to factors like weather, customer demand, and regulatory environment, making it important for investors to closely monitor the company's outlook.